283 related articles for article (PubMed ID: 35889340)
21. Chitosan Nanoparticles for Enhanced Delivery of
Alam P; Imran M; Ahmed S; Majid H; Akhtar A
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004427
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
23. Chitosan-Coated PLGA Nanoparticles Loaded with
Azzazy HME; Fahmy SA; Mahdy NK; Meselhy MR; Bakowsky U
Nanomaterials (Basel); 2021 Sep; 11(9):. PubMed ID: 34578755
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxicity of Chitosan Ultrafine Nanoshuttles on the MCF-7 Cell Line as a Surrogate Model for Breast Cancer.
Faris T; Harisa GI; Alanazi FK; Badran MM; Alotaibi AM; Almanea H; Alqahtani AS; Samy AM
Curr Drug Deliv; 2021; 18(1):19-30. PubMed ID: 32682379
[TBL] [Abstract][Full Text] [Related]
25. Preparation of biocompatible carboxymethyl chitosan nanoparticles for delivery of antibiotic drug.
Zhao L; Zhu B; Jia Y; Hou W; Su C
Biomed Res Int; 2013; 2013():236469. PubMed ID: 23586023
[TBL] [Abstract][Full Text] [Related]
26. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
Gajra B; Patel RR; Dalwadi C
Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
[TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization and evaluation of antibacterial activity of catechins and catechins-Zn complex loaded β-chitosan nanoparticles of different particle sizes.
Zhang H; Jung J; Zhao Y
Carbohydr Polym; 2016 Feb; 137():82-91. PubMed ID: 26686108
[TBL] [Abstract][Full Text] [Related]
28. Application of Box-Behnken experimental design for the formulation and optimisation of selenomethionine-loaded chitosan nanoparticles coated with zein for oral delivery.
Vozza G; Danish M; Byrne HJ; Frías JM; Ryan SM
Int J Pharm; 2018 Nov; 551(1-2):257-269. PubMed ID: 30153488
[TBL] [Abstract][Full Text] [Related]
29. Optimization of particle size and encapsulation efficiency of vancomycin nanoparticles by response surface methodology.
Honary S; Ebrahimi P; Hadianamrei R
Pharm Dev Technol; 2014 Dec; 19(8):987-98. PubMed ID: 24147898
[TBL] [Abstract][Full Text] [Related]
30. Preparation of an optimized ciprofloxacin-loaded chitosan nanomicelle with enhanced antibacterial activity.
Farhangi M; Kobarfard F; Mahboubi A; Vatanara A; Mortazavi SA
Drug Dev Ind Pharm; 2018 Aug; 44(8):1273-1284. PubMed ID: 29452500
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of thermosensitive chitosan hydrogel containing gefitinib loaded cellulose acetate butyrate nanoparticles in a subcutaneous breast cancer model.
Karimi Z; Taymouri S; Minaiyan M; Mirian M
Int J Pharm; 2022 Aug; 624():122036. PubMed ID: 35868480
[TBL] [Abstract][Full Text] [Related]
32. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
Hard SAAA; Shivakumar HN; Redhwan MAM
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522
[TBL] [Abstract][Full Text] [Related]
33. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
[TBL] [Abstract][Full Text] [Related]
34. Design and Evaluation of SLNs Encapsulated Curcumin-based Topical Formulation for the Management of Cervical Cancer.
Singhai M; Pandey V; Ashique S; Gupta GD; Arora D; Haider T; Mishra N
Anticancer Agents Med Chem; 2023; 23(16):1866-1879. PubMed ID: 37365788
[TBL] [Abstract][Full Text] [Related]
35. Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design.
Abul Kalam M; Khan AA; Khan S; Almalik A; Alshamsan A
Int J Biol Macromol; 2016 Jun; 87():329-40. PubMed ID: 26893052
[TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box-Behnken design and response surface methodology.
Gidwani B; Vyas A
Artif Cells Nanomed Biotechnol; 2016; 44(2):571-80. PubMed ID: 25363752
[TBL] [Abstract][Full Text] [Related]
37. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
Bin-Jumah M; Gilani SJ; Jahangir MA; Zafar A; Alshehri S; Yasir M; Kala C; Taleuzzaman M; Imam SS
Int J Nanomedicine; 2020; 15():7861-7875. PubMed ID: 33116505
[TBL] [Abstract][Full Text] [Related]
38. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA
AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176
[TBL] [Abstract][Full Text] [Related]
39.
Zafar N; Uzair B; Menaa F; Khan BA; Niazi MBK; Alaryani FS; Majrashi KA; Sajjad S
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015345
[TBL] [Abstract][Full Text] [Related]
40. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
Rathod VR; Shah DA; Dave RH
Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
